Small-molecule inhibitors of α-synuclein for the treatment of Parkinson's disease: a patent landscape

Pharm Pat Anal. 2020 May;9(3):63-65. doi: 10.4155/ppa-2020-0008. Epub 2020 Jun 30.

Author

Jacques Joubert¹

Affiliation

¹ Pharmaceutical Chemistry, School of Pharmacy, University of the Western Cape, Private Bag X17, Bellville 7535, Western Cape, South Africa.

PMID: 32602809
DOI: 10.4155/ppa-2020-0008

No abstract available

Keywords: Parkinson’s disease; patented small-molecule inhibitors; α-synuclein.

Publication types

Editorial

MeSH terms

Antiparkinson Agents / chemistry
Antiparkinson Agents / pharmacology
Antiparkinson Agents / therapeutic use*
Humans
Parkinson Disease / drug therapy*
Parkinson Disease / metabolism
Patents as Topic*
Treatment Outcome
alpha-Synuclein / antagonists & inhibitors*
alpha-Synuclein / metabolism

Substances

Antiparkinson Agents
alpha-Synuclein